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Abstract
Porcupine (PORCN) is a membrane-bound O-acyl transferase that is required for the palmitoylation of Wnt proteins, and that
is essential in diverse Wnt pathways for Wnt-Wntless (WLS) binding, Wnt secretion, and Wnt signaling activity. We tested if
PORCN was required for the proliferation of transformed cells. Knockdown of PORCN by multiple independent siRNAs
results in a cell growth defect in a subset of epithelial cancer cell lines. The growth defect is transformation-dependent in
human mammary epithelial (HMEC) cells. Additionally, inducible PORCN knockdown by two independent shRNAs markedly
reduces the growth of established MDA-MB-231 cancers in orthotopic xenografts in immunodeficient mice. Unexpectedly,
the proliferation defect resulting from loss of PORCN occurs in a Wnt-independent manner, as it is rescued by re-expression
of catalytically inactive PORCN, and is not seen after RNAi-mediated knockdown of the Wnt carrier protein WLS, nor after
treatment with the PORCN inhibitor IWP. Consistent with a role in a Wnt-independent pathway, knockdown of PORCN
regulates a distinct set of genes that are not altered by other inhibitors of Wnt signaling. PORCN protein thus appears to
moonlight in a novel signaling pathway that is rate-limiting for cancer cell growth and tumorigenesis independent of its
enzymatic function in Wnt biosynthesis and secretion.
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Introduction
Wnts are secreted acylated glycoproteins that can act as
autocrine or short-range signaling molecules and long-range
morphogens. The 19 different human Wnts regulate multiple
signaling pathways, and their dysregulation is implicated in diverse
disorders of development, stem cell biology, proliferation and
angiogenesis [1,2]. There is thus intense interest in manipulation
of the Wnt pathway though intervention at diverse points in Wnt
production and the downstream signaling cascades. One strategy
to achieve broad disruption of Wnt signaling pathways is to
prevent Wnt secretion through inhibition of the PORCN protein.
Porcupine (PORCN) was first discovered as a Drosophila
segment polarity gene necessary for the normal distribution of
Wingless (Wg), the Drosophila homolog of WNT [3]. PORCN is a
member of the Membrane-Bound O-Acyl Transferase (MBOAT)
family and is conserved among species [4,5]. PORCN is a multi-
pass integral membrane enzyme resident in the endoplasmic
reticulum and is required for the lipid modification of Wnt
proteins. Acylation by PORCN appears to be absolutely essential
for the proper secretion and activity of all vertebrate Wnts
[5,6,7,8,9,10,11] and genetic deletion of PORCN is embryonic
lethal [12,13]. PORCN has no known function beyond its role in
the biogenesis of Wnts, and is therefore an attractive therapeutic
target in diseases with increased Wnt signaling. Indeed, several
small molecule inhibitors of PORCN function have been recently
reported, including Inhibitor of Wnt Production 1 and 2 (IWP-1
and IWP-2) [14]. There are two general approaches to PORCN
inhibition, pharmacologic and genetic. Notably, these methods of
PORCN inhibition may give different results. This can be due to
differing durations and degree of inhibition but also because
genetic ablation of an enzyme can unexpectedly unmask multiple
independent functions for a single gene product.
Two sites in Wnt proteins can be acylated: the serine
corresponding to S209 of WNT3A is palmitoleated, while the
cysteine corresponding to Cys77 is palmitoylated [4,11,15].
Ser209 acylation is required for WNT binding to Wntless (WLS)
[16], a highly conserved multipass transmembrane protein
specifically involved in Wnt secretion [17,18,19]. WLS transports
Wnts to the plasma membrane, where they are then released into
the extracellular space in a pH-dependent manner. Consistent
with WLS’s role in Wnt secretion, cells lacking functional WLS
accumulate Wg in the Golgi [17] and mice lacking WLS have
lethal developmental phenotypes consistent with a key role in Wnt
signaling [20]. The role of Wnt cysteine acylation is less clear [21].
Cys77 appears to be involved in signaling activity of the secreted
protein, as mutation of the site results in a secreted protein with
variably reduced signaling activity [15]. Palmitoylation at this site
may be necessary for binding to Frizzled or other receptors.
While PORCN is clearly critical for Wnt secretion and function,
it is not known if it plays additional roles distinct from its
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could acylate additional non-Wnt substrates. Alternatively, since
PORCN is an evolutionarily ancient protein present in the
simplest metazoans [22], it may have co-evolved enzyme-
independent, ‘‘moonlighting’’ functions as well. As PORCN is
both critical in development and a potential therapeutic target in
human disease, it is important to fully understand the role of the
PORCN protein in cells. To dissect the role of PORCN in Wnt-
dependent versus Wnt-independent pathways, we compared the
effect of inhibiting Wnt secretion by multiple means including
PORCN knockdown, WLS knockdown, and small molecule
inhibition of PORCN. We find that PORCN functions in at least
two independent pathways, one that controls Wnt secretion, and a
second that does not require palmitoyl transferase activity but that
is rate-limiting for the growth of transformed epithelial cells and
regulates expression of a distinct set of genes. PORCN’s Wnt-
independent role in rapid proliferation has important implications
for both embryonic development and cancer.
Materials and Methods
Ethics Statement
All experiments conducted on mice address relevant and
necessary scientific questions. These were performed using
recommended anesthesia and analgesics during procedures and
concluded in a timely fashion to prevent unnecessary pain or
burden on the mice. All experiments were performed with the
approval of the NUS Institutional Animal Care and Use
Committee (IACUC).
Cells, plasmids, and reagents
All cancer cell lines were obtained from the ATCC. The STF
and STF3A cells were derived from HEK 293 cells as previously
described [23]. HMEC transformed (hTERT + H-Ras-V12 + p53
knockdown) and immortalized (hTERT) cells were the gift of
Mathijs Voorhoeve, Duke-NUS Graduate Medical School,
Singapore. Male murine embryonic stem (ES) cells with a targeted
PORCN locus that places LoxP sites upstream of exon 8 and
downstream of exon 10 were made by Ozgene. PORCN null
gene-targeted ES cells were selected for by Davor Solter’s lab
(Institute for Medical Biology, Singapore). MDA-MB-231 cells
expressing pTRIPZ were made using lentiviral transduction (Open
Biosystems). The shRNA sequences used were P1:5 9- CCT GGA
TAT CCT TCC ACA GCT -39 P2:5 9- TAT TTA GCC AAT
AAG ACA TGG T -39, W1:5 9- ACC AAG AAG CTG TGC
ATT GTT -39, W5:5 9- TGG ACA TTG CCT TCA AGC TAA-
39. pMKIT-HA-mPORC-D (gift from Tatsuhiko Kadowaki) was
cloned into the retroviral plasmid MSCV-puro (gift from Mathijs
Voorhoeve). Point and siRNA-immune mutants were made using
Stratagene Quikchange site directed mutagenesis. MDA-MB-231
and MCF7 cells stably expressing wildtype and mutant PORCN
were generated by retroviral transduction and selection in
puromycin. The small molecule PORCN inhibitors IWP-1 and
IWP-2 were generously provided by Dr. Lawrence Lum. siRNAs
were from Dharmacon: Control/Non-targeting (#D-001810-01-
05), PORCN 7 (#J-009613-07), PORCN 8 (#J-009613-08), WLS
5( #J-018728-05), beta-catenin 11 (#J-093415-11).
RT-PCR/qPCR. Total RNA was extracted from cells using
Qiagen RNeasy Kit, 1 mg RNA was reverse transcribed using Bio-
Rad iScript cDNA synthesis kit, and qPCR was carried out with
Bio-Rad SsoFast EvaGreen Supermix.
Mouse Tumor Models. For transient knockdown, 100,000
MDA-MB-231 cells were transfected with the indicated siRNAs
(Control or P7) and then injected into the 4
th position mammary
fat pad of 6 week old female NOD-SCID mice. For PORCN and
WLS tumor models, 500,000 MDA-MB-231 cells in 50 ml DMEM
were injected orthotopically into the 4
th position mammary fat pad
of 6 week old female BALB/c nude mice. One week post injection,
the staples were removed and tumor growth was quantified by
caliper measurement. To induce PORCN knockdown, drinking
water was supplemented with doxycycline at 0.5 mg/mL and
refreshed every other day. Upon termination of the study, the
tumors were harvested, weighed, and gene expression was
analyzed.
Proliferation Studies. Cells were plated at 70–80%
confluency in 6-well plates and transfected with the specified
siRNAs at 100 nM using Dharmafect 1 following the
manufacturer’s protocol. 24 h post transfection, cells were
trypsinized and replated at a 1:40 to 1:80 dilution in 12-well
plates. For proliferation studies with IWP, cells were plated into
12-well plates at 10% confluency. Media containing vehicle
(DMSO) or IWP-1/2 was refreshed daily. The 12-well plates were
collected over a 7-day period, fixed with ice-cold MeOH, and
stained with crystal violet (0.5% CV in 25% MeOH). To quantify
cell number, the crystal violet was solubilized in 1% sodium
deoxycholate in water and absorbance was measured at 590 nm.
Parallel experiments were performed and cells were trypsinized
and counted with a Beckman Coulter Counter over a 7-day
period.
Microarray. MDA-MB-231 cells (70–80% confluent) were
transfected with 50 nM siRNA for 48 hours. RNA was isolated
using RNeasy purification kit from Qiagen. Labeled cRNA was
prepared and hybridized to Affymetrix U133_Plus_2.0
microarrays according to the manufacturer’s protocols. The
array data was normalized using RMA algorithm. 1482 varying
genes are detected by 1 way ANOVA algorithm (False Discovery
Rate (FDR),=0.01). Hierarchical clustering analysis identifies
significantly different groups of samples from 1482 varying genes.
Analysis was carried out using Partek software.
Results
PORCN is required for Wnt secretion
To generate tools for investigating PORCN function, we
identified and validated two independent and non-overlapping
siRNAs, siP7 and siP8, that target all splice variants of PORCN
and gave greater than 90% knockdown of PORCN mRNA
(Figure 1A) in HEK-293 cells. As expected, knockdown of
PORCN in the presence of transfected WNT3A resulted in a
decrease in b-catenin/TCF-driven luciferase expression in HEK-
293 cells with an integrated SuperTopFlash reporter (STF cells)
(Figure 1B). Likewise, knockdown of PORCN in STF cells with
stable integration of WNT3A (STF3A cells) resulted in a defect of
WNT3A secretion into the medium (Figure 1C), consistent with
PORCN’s essential role in Wnt secretion.
Loss of PORCN inhibits breast cancer cell growth
To test if PORCN was important for breast cancer cell
proliferation we first assessed its expression in a panel of breast
cancer cell lines. PORCN mRNA was present in all lines tested,
with MDA-MB-231 and SUM-159 cells displaying the most
abundant message (Figure S1A). We additionally analyzed these
cells for basal Wnt/b-catenin signaling but did not see consistent
or statistically significant activation of TOPFlash over the negative
control FOPFlash reporter in any of the cell lines tested (data not
shown). Although some of these cell lines have been reported to
have endogenous Wnt/b-catenin activation due to upregulation of
Wnts and silencing of secreted Wnt inhibitors [24,25,26], under
Wnt-Independent Effects of PORCN
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loop.
Because Wnt signaling can activate both b-catenin dependent
and b-catenin-independent pathways, we tested if PORCN
knockdown affected the proliferation and survival of these human
breast cancer cell lines even in the absence of detectable
endogenous b-catenin signaling. PORCN siRNAs siP7 and siP8
were able to produce at least 75% knockdown of PORCN mRNA
in MDA-MB-231 cells (Figure 1G). Unexpectedly, this caused a
marked decrease in cell proliferation over time (Figure 1D). These
findings were extended in five additional breast cancer cell lines;
RNAi-mediated knockdown of PORCN caused a statistically
significant decrease in proliferation (Figure 1E) in each cell line
tested. RNAi-mediated knockdown of PORCN has been reported
to cause apoptosis in human lung cancer cells [27], although this
finding could not be independently reproduced [28]. While we
found a decrease in growth in a number of breast cancer cell lines,
PORCN knockdown did not result in apoptosis or a shift in cell
Figure 1. Knockdown of PORCN affects breast cancer cell proliferation. A. STF3A cells were transfected with 100 nM of the indicated siRNA
and PORCN message was analyzed 48 hrs later by quantitative real time PCR. Histogram represents relative PORCN mRNA normalized to Actin mRNA.
NT, not transfected; siC, siRNA control; siP7 and siP8, specific PORCN siRNAs. B. PORCN knockdown blocks Wnt/b-catenin signaling. Relative Wnt/b-
catenin signaling was measured in STF3A cells transfected with 100 nM of siC, siP7, or siP8 siRNA. C. PORCN knockdown inhibits WNT3A secretion.
STF3A cells were transfected with 100 nM of the indicated siRNA. Media was changed to 1% FCS media 48 hours after transfection, and collected
16 hrs later. The abundance of WNT3A was assessed in 30 mL conditioned media (Media) and 15 mg of whole cell lysates (WC) by SDS-PAGE and
immunoblotting with the indicated antibodies. Actin immunoblotting demonstrates equal loading of whole cell lysates. D. Relative numbers of MDA-
MB-231 breast cancer cells is decreased after PORCN knockdown. Cells were transfected with the indicated siRNAs and proliferation assessed as in
Experimental Procedures. Error bars indicate standard deviation. E. PORCN knockdown slows the growth of multiple breast cancer cell lines. Cell
number was assessed 4 days post-transfection of siP7 siRNA and plotted as % of proliferation of control siRNA-transfected cells. *, p,0.05; **, p,0.01
for difference from control. F. PORCN knockdown selectively slows the growth of transformed hMECs. The effect of PORCN knockdown on the growth
of hMECs immortalized with hTERT or hMEC-hTERT cells transformed by expression of H-RasV12 and stable knockdown of p53 was assessed 6 days
after transfection with control or siP7 siRNA. Transfection efficiency in both cell types was .80% as assessed by GFP expression. *, p,0.05 compared
with control siRNA. G. PORCN knockdown alters expression of Wnt/b-catenin target genes. Relative message of PORCN and other Wnt/b-catenin
target genes in MDA-MB-231 cells (top) and SK-BR-3 cells (bottom) was assessed by qRT-PCR 72-hrs after transfection with 100 nM of the indicated
siRNA.
doi:10.1371/journal.pone.0034532.g001
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data not shown). Notably, PORCN knockdown does not affect the
proliferation of all cells. For example, mesoderm-derived cancer
lines such as HT-1080 fibrosarcoma cells and transformed BJ
fibroblasts were not measurably affected (data not shown). Also,
PORCN is not essential for the growth of embryonic stem cells
and mouse embryo fibroblasts [12,13]. Importantly, the growth
effect of PORCN knockdown is transformation specific in
epithelial cells. Transformed hMECs are sensitive to PORCN
knockdown whereas immortalized HMECs are not affected
(Figure 1F). Consistent with the finding that the effect of PORCN
knockdown on growth is not dependent on Wnt signaling, the
transformed hMECs do not display any evidence of Wnt/b-
catenin autocrine signaling (data not shown).
The consequences of PORCN knockdown were examined
further by assaying endogenous Wnt target genes in SK-BR-3 and
MDA-MB-231 cells, as they had the largest proliferation defect
after PORCN knockdown. These lines have been reported to have
autocrine Wnt signaling [24,29], although we could not detect this
in TOPFLASH assays in our specific cell lines. PORCN
Figure 2. Inducible knockdown of PORCN delays cancer growth in an orthotopic xenograft model. A. Establishment of PORCN inducible
knockdown. MDA-MB-231 cells with stable integration of pTRIPZ- shC (control), -shP1, or -shP2 shRNAmir were treated with 5 ng/mL Doxycycline
(right) or vehicle control (left). PORCN and Actin mRNA were assessed by RT-PCR, and RFP expression was assessed by fluorescence microscopy. B.
Inducible knockdown of PORCN inhibits Wnt/b-catenin signaling. The stable MDA-MB-231 cell lines were transiently transfected with WNT3A
expression vector and SuperTOPflash and Renilla luciferase reporter plasmids, and then treated with 5 ng/mL Dox for 48 hrs before assessment of
Wnt/b-catenin signaling as described. Histogram represents SuperTOPflash signaling relative to Renilla luciferase expression. C. Inducible knockdown
of PORCN mRNA in orthotopic xenografts. The stable cell lines were injected orthotopically into the 4
th mammary fat pad of BALB/c nude mice. After
establishment of palpable tumors (15 days), Dox was added to the water for a 7 day period, tumors were harvested and mRNA abundance was
assessed by qRT-PCR. Histogram represents relative PORCN mRNA normalized to Actin mRNA. D. PORCN knockdown slows cancer growth. Tumors
were harvested and weighed 19 days after the start of doxycycline treatment. E. Cancer growth is slowed by inducible PORCN knockdown. Tumor
volume was measured by calipers at the indicated times.
doi:10.1371/journal.pone.0034532.g002
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significant decrease in the abundance of transcripts encoding the
Wnt target genes AXIN2, Cyclin D, and LEF1 (Figure 1G, top
panel). A significant decrease of both AXIN2 and LEF1 mRNA
was found in SK-BR-3 cells (Figure 1G, bottom panel). Taken
together, PORCN knockdown decreased the growth rate of a
number of transformed cell lines, and this correlated imperfectly
with knockdown of Wnt/b-catenin target gene including AXIN2,
Cyclin D and CMYC.
Knockdown of PORCN slows tumor growth in an
orthotopic mouse model
To address whether PORCN knockdown might slow the
growth of tumor cells in a more complex environment where
additional stroma-derived signals can also stimulate proliferation,
we investigated the rate of establishment of tumors in vivo. MDA-
MB-231 cells transfected with siControl or siP7 siRNA were
orthotopically injected into NOD-SCID mice and tumor take was
monitored. MDA-MB-231 cells with transient PORCN knock-
down displayed a 2-week delay in tumor take compared to controls
(Figure S1C). Delay in tumor formation suggested that PORCN
gene function is important to tumor take and/or progression and
encouraged us to pursue a stable knockdown approach.
To test if loss of PORCN would affect the growth of established
tumors, we screened 25 mIR-30 based constructs and identified
two independent microRNAs that provided robust PORCN
knockdown. These were cloned into an inducible lentiviral vector,
pTRIPZ, that provides dual expression of Red Fluorescent Protein
(RFP) and the shRNAmir in the presence of doxycycline. MDA-
MB-231 cells were generated with stably integrated pTRIPZ
driving either scrambled shRNAmir (shControl) or one of two
independent shRNAmirs against all splice variants of PORCN
(here called shP1 and shP2). In cultured cells, addition of
doxycycline led to induction of the shRNAmir with ,75%
reduction of PORCN message and high expression of RFP
(Figure 2A). As expected, this decrease in PORCN mRNA in the
MDA-MB-231 cells led to a decrease in WNT3A-activated
signaling from the STF reporter (Figure 2B). To test whether
PORCN knockdown could be induced in vivo, cells were injected
orthotopically into BALB/c nude mice. When tumors reached a
palpable size (,0.2 cm), doxycycline was added to the drinking
water. After 7 days on doxycycline, tumors were collected and
analyzed for PORCN message. Both shP1 and shP2 tumors had a
reduction in PORCN message, indicating that doxycycline is
reaching the cells and inducing PORCN knockdown in vivo
(Figure 2C).
To test whether PORCN knockdown affects tumor growth, the
same cell lines were injected orthotopically into BALB/c nude
mice. Tumors were allowed to reach ,0.2 cm in diameter (about
2 weeks post injection), and then PORCN knockdown was
induced by adding doxycycline to the water. After induction by
doxycyline, there was a significant reduction in the rate of growth
of tumors expressing either shP1 or shP2 (Figure 2E). This
appeared to be dose dependent, as shP1 produced both a greater
knockdown of PORCN and a greater reduction in tumor growth
(Figure 2C and E). Once the control tumors reached ,1c mi n
diameter, the mice were sacrificed. Tumors were excised, weighed
and measured. Tumors were significantly smaller and lighter if
they contained the induced shP1 or shP2 shRNAmir (Figure 2D).
These results demonstrate that knockdown of PORCN mRNA in
an established orthotopic breast cancer results in a significant
delay in tumor growth. Thus, PORCN plays a critical role in
MDA-MB-231 cell proliferation both in culture, and in xenografts.
Loss of PORCN affects cancer cell growth in a Wnt-
independent manner
The above results show that knockdown of PORCN regulates
proliferation of multiple breast cancer cell lines. The effect on
proliferation is not due to off-target effects of the RNAi, since we
obtained identical results with two independent siRNAs and two
additional independent shRNAmirs against a total of 4 different
regions of PORCN. Importantly, all the RNAi constructs were
within coding sequence contained within each of the four human
PORCN splice variants. Because the effect of PORCN knockdown
did not correlate strongly with its effect on b-catenin dependent
genes such as AXIN2, CYCLIN D, and CMYC, we considered
the possibility that PORCN knockdown might decrease cell
growth through a b-catenin independent autocrine Wnt loop or,
alternatively, that PORCN has some additional, Wnt-independent
functions. To differentiate between these possibilities, we inhibited
Wnt secretion by two additional independent approaches.
Acylation of Wnts by PORCN is required for their binding to
the transport protein, WLS, which carries Wnts from the ER or
Golgi to the plasma membrane prior to secretion [16]. As such,
pharmacological inhibition of acylation and loss of WLS both
inhibit Wnt secretion akin to PORCN knockdown [17,18]. Insofar
as we know to date, all mammalian Wnts require both PORCN
and WLS for secretion. As expected, siRNA knockdown of WLS
and PORCN all similarly and effectively inhibited WNT3A-driven
signaling (Figure 3A). PORCN enzymatic function can be
inhibited with the small molecule inhibitor IWP-1 [14]. Similar
to published results, we found that IWP-1 inhibits Wnt secretion
into the medium with an IC50 of ,200 nM (Figure 3B). IWP-1
also effectively inhibits WNT3A-driven signaling in MDA-MB-
231 cells at similar doses (Figure 3C). Using these alternative
approaches, we examined the consequence of decreased Wnt
secretion on cancer cell growth.
Surprisingly, unlike PORCN knockdown, knockdown of WLS
had little or no effect on the proliferation of any cancer cell line
tested, including MDA-MB-231, MCF7, DLD-1, SK-BR-3,
T47D, and HeLa cells (Figure 3D and data not shown). Likewise,
b-catenin knockdown did not affect cell growth in MDA-MB-231
or MCF7 cells. Confirming the efficacy of knockdown, loss of b-
catenin significantly decreased the proliferation of DLD-1 cells,
which have stabilized b-catenin due to a mutation in the
adenomatous polyposis coli (APC) gene (Figure 3D). The small
effect of b-catenin knockdown on MDA-MB-231 cell proliferation
in this experiment was not seen in repeat experiments.
Furthermore, addition of IWP-1 at doses that give .80%
reduction of Wnt/b-catenin signaling had no effect on the cell
growth or viability of MDA-MB-231, MCF7, and DLD-1 cells,
lines that were sensitive to both PORCN siRNA and shRNA
(Figure 3D). We extended this result to a panel of other cancer cell
lines and also found no effects of IWP-1 or the related molecule
IWP-2 on cell growth and viability (Figure S2). These results
demonstrate that blockade of Wnt secretion by WLS knockdown
or IWP treatment did not alter cancer cell proliferation and
survival, implying that these cells do not depend on autocrine Wnt
signaling. Importantly, this data suggests that loss of PORCN may
therefore affect growth in a Wnt independent manner.
Loss of WLS does not affect tumor take or growth
Because of the surprising lack of effect of WLS knockdown in
cell culture, we sought to extend this result to a tumor model.
MDA-MB-231 cells were stably transduced with one of two
shRNA targeting WLS (shW1 and shW5) or a control shRNA,
(shC). Both shRNA targeting WLS gave an effective knockdown at
the mRNA (.80%) and at the protein level (Figure 3E). These
Wnt-Independent Effects of PORCN
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tumor progression was monitored. Tumors from all three lines
grew at a very similar rate (Figure 3F). When tumors reached
,1 cm in diameter, they were removed and assessed for
persistence of WLS knockdown. Both shW1 and shW5 maintained
a .60% knockdown of WLS in the tumors (Figure 3G). Thus,
while WLS knockdown is effective, persistent, and diminishes b-
catenin signaling, it has no effect on MDA-MB-231 cell growth or
xenograft tumors. Taken together with the effect of PORCN
knockdown on tumor growth (Figure 2E), this data further
Figure 3. PORCN knockdown has Wnt/b-catenin-independent effects. A. WLS, b-catenin, and PORCN knockdown all inhibit Wnt/b-catenin
signaling in STF3A cells. The following siRNAs were used at 100 nM: for PORCN, siP7; for WLS, siW5; for b-catenin, sibC11. B. IWP-1 inhibits WNT3A
secretion. Conditioned medium from STF3A cells was assessed for WNT3A as described after cells were incubated for 16 hours in the presence of the
indicated concentration of IWP-1. C. IWP-1 inhibits WNT3A-driven signaling in MDA-MB-231 cells. MDA-MB-231 cells were co-transfected with WNT3A
and STF, and treated overnight with vehicle (DMSO) or indicated doses of IWP-1. D. The indicated cell lines were either transfected with siRNAs as
above, or treated with IWP-1 or vehicle control. Total cell count at day 6 was assessed as described and compared with untreated cells. IWP-1 was
used at 2 mM and refreshed every 24 h. E. Western blot of WLS in MDA-MB-231 cells stably expressing shC, shW1, and shW5 shRNAs. F. WLS
knockdown does not slow tumor growth. MDA-MB-231 cells stably expressing shC, shW1, and shW5 shRNAs were injected orthotopically into BALB/C
nude mice and tumor growth monitored as described. G. WLS message levels in tumors extracted from (E), assessed by qRT-PCR and normalized to
Actin.
doi:10.1371/journal.pone.0034532.g003
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cell growth in vivo
Wild Type and mutant PORCN both rescue growth
effects
PORCN knockdown slowed cancer proliferation, unlike
inhibition of PORCN enzymatic activity with the small molecule
IWP-1. This paradox suggested that PORCN protein might play a
required structural role in cells. To confirm that loss of PORCN
protein is responsible for the observed growth effects, we sought to
rescue this phenotype by using an siRNA-immune version of
mouse PORCN-D. Using an MSCV-3XHA-tagged mPORCN-D
construct [4], we used site directed mutagenesis to give immunity
to siP7 siRNA. To make catalytically inactive PORCN, we
mutated H341, an invariant MBOAT catalytic residue predicted
to participate in PORCN catalytic activity. Experiments in several
PORCN-null cell lines confirmed that mPORCN(H341A) is
completely catalytically inactive (Figure 4E and data not shown).
In addition, PORCN(H341L) has recently been shown to be
catalytically inactive in PORCN null ES cells [13]. In transient
transfections, the PORCN mutant protein was expressed at levels
similar to wildtype PORCN and acts in a dominant negative
manner, effectively inhibiting both Wnt secretion and TCF-driven
luciferase expression in STF3A cells (Figure S3, A–C). Using
siRNA-immune versions of these constructs, we cotransfected
MDA-MB-231 cells with siP7 siRNA and showed it had no effect
on abundance of the ectopic PORCN protein (Figure 4A, top
panel), confirming immunity to the siP7 siRNA. MDA-MB-231
cells expressing wildtype mPORCN have increased WNT3A-
driven STF activity (Figure 4B). Notably, MDA-MB-231 cells
expressing H341A mPORCN have reduced WNT3A-driven b-
catenin signaling activity, consistent with a dominant negative
function in MDA-MB-231 cells as well. Both wildtype and H341A
PORCN co-localize with calnexin (Figure 4C), an ER marker
[30], consistent with previous reports showing PORCN localiza-
tion to the ER [4].
To test if the growth defect caused by PORCN knockdown
could be rescued by re-expression of a catalytically inactive,
dominant negative PORCN, growth assays were performed in
MDA-MB-231 cells transiently transfected with either empty
vector (EV), wildtype (WT), or H341A-PORCN expression
constructs and co-transfected with siControl or siP7. As seen
previously, the MDA-MB-231 cells responded to PORCN
knockdown with a reduction in cell growth (Figure 4D). Ectopic
WT-PORCN significantly rescued the growth when endogenous
PORCN was knocked down (Figure 4D). Remarkably, cells
exhibited identical growth rescue when catalytically inactive
H341A-PORCN was expressed (Figure 4D). Rescue with
catalytically inactive H341A-PORCN is consistent with our
finding that pharmacological inhibition of PORCN and knock-
down of WLS have no effect on MDA-MB-231 cell proliferation.
Rescue of the proliferation defects by a catalytically inactive
mutant suggests that PORCN is playing an essential, possibly
structural, role in the endoplasmic reticulum that is independent of
its ability to support Wnt acylation and secretion.
PORCN Regulates a Distinct Subset of Genes in a Wnt
Independent Manner
Because of the surprising differences between loss of PORCN
and WLS on cell growth, we further investigated whether PORCN
and WLS function in distinct pathways by examining the effect of
knockdown on gene expression profiles. MDA-MB-231 cells were
transfected with mock, siControl, siP7, siP8, or siW5 siRNA.
mRNA was harvested 48 hrs later for gene expression analysis.
Gene expression changes following WLS knockdown did not differ
much from control siRNA, consistent with the low levels of
autocrine signaling in our cell lines. Unexpectedly, the expression
profiles after PORCN or WLS knockdown were significantly
different, with only a few genes coordinately regulated (Figure 5A).
Interestingly, distinct subsets of genes were up- or down-regulated
by PORCN knockdown that were unchanged after WLS
knockdown, a finding that was repeated and confirmed by qPCR
(Figure 5B). For example, PORCN knockdown produced a 60%
reduction in LAMC expression and a 2.5-fold increase in
ADAMTS1 expression, while 90% knockdown of WLS had no
effect on these genes. One of the genes whose expression was most
significantly down-regulated by PORCN knockdown was N-
acylaminoacyl-peptide hydrolase (APEH). APEH catalyzes the
hydrolysis of N-acetylated amino acids from small acetylated
peptides or proteins [31]. We confirmed that PORCN knockdown
caused downregulation of both APEH mRNA (Figure 5B) and
protein (Figure 5C) in MDA-MB-231 cells. The regulation of
APEH by PORCN was consistent across cell lines; for example,
MCF7, T47D, and DLD-1 cells also exhibited APEH downreg-
ulation with PORCN knockdown (Figure 5D). The regulation of
APEH is Wnt-independent, as WLS knockdown has no effect on
APEH mRNA (Figure 5B) or protein levels (data not shown). IWP-
1 treatment also had no effect on APEH levels (data not shown).
Importantly, APEH expression in PORCN-knockdown cells was
rescued by ectopic expression of both wildtype and H341A-
PORCN (Figure 5E), further demonstrating that catalytically
inactive PORCN regulates pathways independent of its function of
palmitoylating Wnt proteins.
The transcription of ADAMTS1, APEH, LAMC, and RALBP1
has no obvious functional relationship with PORCN, which is an
ER-resident protein. The effects on transcription could be a direct
consequence of disruption of an ER function leading to changes in
intracellular signaling, or an indirect and secondary consequence
of loss of PORCN function. We could find no evidence of
activation of the ER stress response pathway (data not shown). We
also tested whether direct knockdown of APEH, RALBP1, or
LAMC in MDA-MB-231 cells recapitulated the PORCN
knockdown slow growth phenotype. However, no single gene
knockdown reproduced this effect. We speculate that a combina-
tion of genes that are up- or down-regulated by PORCN
knockdown are responsible for the altered proliferation seen in
transformed epithelial cells. Taken together, the data indicate
PORCN plays two roles in the ER, one to acylate Wnts, and
independently, one to participate non-enzymatically in a pathway
that is rate-limiting for transformed epithelial cell growth
(Figure 5F).
Discussion
In this report, we investigated the role of PORCN in
proliferation and survival in tumorigenesis. We found that
PORCN knockdown inhibits the growth of a number of epithelial
cancer cell lines. Surprisingly, these cells have little or no evidence
of autocrine Wnt signaling, suggesting that the effect on
proliferation is independent of Wnt/b-catenin signaling. Support-
ing this, unlike PORCN knockdown, WLS knockdown, b-catenin
knockdown, and pharmacological inhibition of PORCN do not
affect growth of these cell lines. This unexpected function of
PORCN in cell growth is also independent of its catalytic function
as an acyltransferase, as we can rescue both growth and changes in
gene expression with a catalytically inactive, dominant negative
mutant of PORCN. Taken together, our data strongly suggests
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epithelial cancer cells.
There is increasing recognition that enzymes can have additional
functions alongside their catalytic roles. This phenomenon is called
‘moonlighting’, where proteins perform multiple different functions
using the same protein domain (reviewed recently by [32,33].
Moonlighting appears to be more common in highly conserved
enzymes, although the known proteins that can moonlight are
rapidly expanding. Some examples of moonlighting include
metabolic enzymes such as glyceraldehyde-3-phosphate dehydroge-
nase and lactate dehydrogenase and signaling kinases such as Akt,
Erk2 and the pyruvate kinase splice variant M2 [34]. Our data
suggest that the evolutionarily ancient PORCN protein has also
evolvedadditional roles that are independentof itscatalyticfunction.
An intriguing insight into PORCN moonlighting function is that
it is not rate limiting for growth in all cell types, but rather only in
Figure 4. Wild type and mutant PORCN both rescue the slow growth phenotype. A. Western blot analysis of MDA-MB-231 cells transfected
with P7 immune constructs of HA-tagged WT and H341A PORCN. The PORCN construct contains 2 additional silent mutations that render it immune to
P7 siRNA knockdown. EV, empty vector; WT, wildtype PORCN-HA; MT, H341A-PORCN-HA. B. Wildtype but not mutant PORCN stimulates Wnt/b-catenin
signaling. MDA-MB-231 cells were co-transfected with plasmids encoding for WT- and H341A-PORCN, WNT3A, and the SuperTOPflash reporter. H341A-
PORCN has a significant dominant negative effect on Wnt/b-catenin signaling. C. Wildtype and mutant PORCN are appropriately localized. Indirect
immunofluorescence microscopy was performed with anti-HA antibody and the endoplasmic reticulum marker calnexin. D. Wildtype and dominant
negative H341A PORCN are equally effective at rescuing the growth defect caused by PORCN knockdown. MDA-MB-231 were co-transfected with P7
siRNA and PORCN expression constructs as indicated. Cell numbers were measured as described. Histogram represents cell number at day 5. *, p,0.01
for ability of constructs to rescue slowed proliferation; **, p,0.01 for ability of PORCN knockdown to slow proliferation relative to control. E. WT but not
H341A-PORCN is able to rescue Wnt/b-catenin signaling. PORCN null ES cells were co-transfected with plasmids encoding WT- and H341A-PORCN,
WNT3A, and the SuperTOPflash reporter. In the absence of ectopic PORCN in these ES cells, there is no WNT3A-driven signaling.
doi:10.1371/journal.pone.0034532.g004
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the proliferation of HEK 293 cells, HT1080 fibrosarcoma cells,
non-transformed HMECs, or BJ foreskin fibroblast cell lines
regardless of transformation status. Complete genetic knockout of
PORCN also did not affect the proliferation of pluripotent stem
cells, as murine ES cells with inactivation of PORCN are able to
both grow in culture [12,13,35] and form teratomas in nude mice
(TMC, manuscript in preparation). It is known that cells undergo
significant stresses during malignant transformation, including
changes in metabolic flux, oxidative stress, checkpoint activation
and apoptotic signaling. It is possible that PORCN’s moonlighting
role becomes rate limiting as part of the adaptation to the
oncogenic transformation in certain epithelial cancers. These
epithelial-specific functions may provide insight into the mecha-
nism of PORCN’s moonlighting function.
The exact moonlighting function of PORCN remains unknown.
A recent paper investigating PORCN in Non Small Cell Lung
Carcinoma illustrated that loss of PORCN downregulates S100P
at the mRNA and protein levels in a b-catenin independent
manner [28], similar to what we have shown for APEH. As
PORCN is an integral ER membrane protein, it seems most likely
that its loss disrupts an ER process. Further insights may come
from identifying PORCN-interacting proteins in the ER, and/or
by following the signaling pathways that alter expression of APEH.
Mutations in PORCN cause an X-linked inherited disorder
called Focal Dermal Hypoplasia (FDH) [36,37]. While FDH is
thought to be the result of defective Wnt signaling, our finding
raises the possibility that the disruption of the moonlighting
function of PORCN may in some cases contribute to the
pathogenesis of the disease. In FDH, there are over 25 different
mutations of PORCN found that have not been extensively
characterized biochemically, and the severity of the disease varies
greatly [38]. It is possible that a subset of these mutations might
alter proliferation in a developmental context in a Wnt-
Figure 5. PORCN regulates a subset of genes in a Wnt-independent manner. A. Gene expression analysis of MDA-MB-231 cells 48 hours
after mock transfected (NT) or transfected with 100 nM of indicated siRNA for 48 hrs. PORCN and WLS differentially regulate a distinct subset of
genes. B. To illustrate genes differentially regulated by PORCN, the abundance of the indicated transcripts were assessed by qRT-PCR 48 hours after
transfection of MDA-MB-231 cells with the indicated siRNAs C. Two independent PORCN siRNAs cause decrease in APEH protein. Immunoblot analysis
of APEH and Actin from MDA-MB-231 cells treated with 100 nM Control (C), PORCN7 (P7) or PORCN8 (P8) siRNA for 72 hrs. D. PORCN knockdown
triggers loss of APEH in multiple cell lines. Immunoblot analysis of APEH from MCF7, T47D, and DLD-1 cells transfected with 100 nM Control (C), or
PORCN7 (P7) siRNAs for 72 hrs. Top panel is 10 s exposure, middle panel is 30 s exposure. Actin (bottom panel) serves as a load control. E. Loss of
APEH is blocked by RNAi-immune wildtype and mutant PORCN. Immunoblot analysis of APEH and HA-tagged PORCN in MDA-MB-231 cells co-
transfected with P7-resistant WT or H341A PORCN and 100 nM Control (C) or PORCN7 (P7) siRNA for 48 hrs. *=non-specific band recognized by anti-
HA antibody, used as load control. Experiment done in duplicate with same results. F. Model of PORCN’s function in transformed epithelial cells.
PORCN is involved in the acylation and secretion of Wnt proteins. Independent of its role in Wnt secretion, PORCN regulates proliferation and gene
expression. The role in gene expression may lead to changes in proliferation.
doi:10.1371/journal.pone.0034532.g005
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lead to premature stop codons. Evidence against this is our data
showing the moonlighting function is not obviously rate limiting in
fibroblasts and non-transformed epithelial cells in culture.
However, PORCN expression has been identified in tissues not
associated with Wnt ligand expression during the development of
mice, such as the anterior visceral endoderm [12]. Our data raises
the possibility that PORCN expression in these tissues may be
important for Wnt-independent functions.
The goal of this study was to investigate the role of PORCN in
tumorigenesis. We have discovered that PORCN knockdown
affects cancer cell growth and tumorigenesis in a Wnt-independent
manner. This study is the first to implicate a Wnt-independent role
of PORCN in cancer cells. Further investigation of the Wnt-
independent roles of PORCN in the endoplasmic reticulum may
provide insights into both novel functions of PORCN and the
endoplasmic reticulum in proliferation.
Supporting Information
Figure S1 Analysis of PORCN and PORCN knockdown
in breast cancer cells and tumorigenesis. A. PORCN
message relative to Actin in a panel of breast cancer cell lines B.
Tumor take of MDA-MB-231 cells transfected with 100 nM of siC
or siP7 and injected orthotopically into nude mice. Transient
knockdown of PORCN resulted in a 2 week delay in tumor take.
C. FACS profile of MDA-MB-231 cells following 72 hr transfec-
tion with 100 nM of Cont, P7, P8, or W5 siRNAs. Although total
cell number was less in the P7 and P8 treated cells, there is no
significant induction in apoptosis or change in cell cycle profile.
(TIF)
Figure S2 IWP-1 and IWP-2 small molecule inhibitors
do not affect cell growth or viability. A. Cell viability of a
panel of breast cancer cells treated with IWP-2 for a 5 day period.
*These concentrations of IWP-2 were not entirely soluble and
formed visible precipitates. B. Growth assay of a panel of cancer
cells treated with 1 mM IWP-1. Following 6 days of treatment, the
cells were fixed with MeOH and stained with crystal violet.
(TIF)
Figure S3 H341A-PORCN affects Wnt signaling and
WNT3A secretion in STF cells. A. Relative Wnt signaling in
STF3A cells transfected with empty vector or WT or H341A
mPORCN-D. B. WNT3A secretion into the media from STF3A
cells transfected with empty vector or WT or H341A mPORCN-
D. C. Relative expression of WT or H341A mPORCN-D
transfected into STF3A cells.
(TIF)
Acknowledgments
We thank Shinji Takada for providing the WNT3A mAb, Yu Jia for the
WLS mAb, Chin Yan Lim for ES cell work, and Lawrence Lum for
providing IWP-1 and IWP-2. We thank Gary Coombs and Shirish
Shenolikar for their critical reading of this manuscript. We also thank Ha
Yin Lee for excellent technical assistance.
Author Contributions
Conceived and designed the experiments: TMC DMV. Performed the
experiments: TMC SK TTO KDP . Analyzed the data: TMC YW.
Contributed reagents/materials/analysis tools: PT. Wrote the paper: TMC
DMV.
References
1. Coombs GS, Covey TM, Virshup DM (2008) Wnt signaling in development,
disease and translational medicine. Curr Drug Targets 9: 513–531.
2. Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17:
45–51.
3. Kadowaki T, Wilder E, Klingensmith J, Zachary K, Perrimon N (1996) The
segment polarity gene porcupine encodes a putative multitransmembrane
protein involved in Wingless processing. Genes Dev 10: 3116–3128.
4. Tanaka K, Okabayashi K, Asashima M, Perrimon N, Kadowaki T (2000) The
evolutionarily conserved porcupine gene family is involved in the processing of
the Wnt family. Eur J Biochem 267: 4300–4311.
5. Caricasole A, Ferraro T, Rimland JM, Terstappen GC (2002) Molecular cloning
and initial characterization of the MG61/PORC gene, the human homologue of
the Drosophila segment polarity gene Porcupine. Gene 288: 147–157.
6. Galli LM, Burrus LW (2011) Differential palmit(e)oylation of Wnt1 on C93 and
S224 residues has overlapping and distinct consequences. PLoS One 6: e26636.
7. Zhai L, Chaturvedi D, Cumberledge S (2004) Drosophila wnt-1 undergoes a
hydrophobic modification and is targeted to lipid rafts, a process that requires
porcupine. J Biol Chem 279: 33220–33227.
8. Komekado H, Yamamoto H, Chiba T, Kikuchi A (2007) Glycosylation and
palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a.
Genes Cells 12: 521–534.
9. Galli LM, Barnes TL, Secrest SS, Kadowaki T, Burrus LW (2007) Porcupine-
mediated lipid-modification regulates the activity and distribution of Wnt
proteins in the chick neural tube. Development 134: 3339–3348.
10. Herr P, Basler K (2011) Porcupine-mediated lipidation is required for Wnt
recognition by Wls. Dev Biol.
11. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, et al. (2006)
Monounsaturated fatty acid modification of Wnt protein: its role in Wnt
secretion. Dev Cell 11: 791–801.
12. Biechele S, Cox BJ, Rossant J (2011) Porcupine homolog is required for
canonical Wnt signaling and gastrulation in mouse embryos. Dev Biol 355:
275–285.
13. Barrott JJ, Cash GM, Smith AP, Barrow JR, Murtaugh LC (2011) Deletion of
mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of
human focal dermal hypoplasia/Goltz syndrome. Proc Natl Acad Sci U S A
108: 12752–12757.
14. Chen B, Dodge ME, Tang W, Lu J, Ma Z, et al. (2009) Small molecule-
mediated disruption of Wnt-dependent signaling in tissue regeneration and
cancer. Nat Chem Biol 5: 100–107.
15. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003)
Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature
423: 448–452.
16. Coombs GS, Yu J, Canning CA, Veltri CA, Covey TM, et al. (2010) WLS-
dependent secretion of WNT3A requires Ser209 acylation and vacuolar
acidification. J Cell Sci 123: 3357–3367.
17. Banziger C, Soldini D, Schutt C, Zipperlen P, Hausmann G, et al. (2006)
Wntless, a conserved membrane protein dedicated to the secretion of Wnt
proteins from signaling cells. Cell 125: 509–522.
18. Bartscherer K, Pelte N, Ingelfinger D, Boutros M (2006) Secretion of Wnt
ligands requires Evi, a conserved transmembrane protein. Cell 125: 523–533.
19. Ching W, Nusse R (2006) A dedicated Wnt secretion factor. Cell 125: 432–433.
20. Fu J, Ivy Yu HM, Maruyama T, Mirando AJ, Hsu W (2011) Gpr177/mouse
Wntless is essential for Wnt-mediated craniofacial and brain development. Dev
Dyn 240: 365–371.
21. Doubravska L, Krausova M, Gradl D, Vojtechova M, Tumova L, et al. (2011)
Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for
lipidation at cysteine and is essential for Wnt signalling. Cell Signal 23: 837–848.
22. Srivastava M, Begovic E, Chapman J, Putnam NH, Hellsten U, et al. (2008) The
Trichoplax genome and the nature of placozoans. Nature 454: 955–960.
23. McCulloch MW, Coombs GS, Banerjee N, Bugni TS, Cannon KM, et al. (2009)
Psammaplin A as a general activator of cell-based signaling assays via HDAC
inhibition and studies on some bromotyrosine derivatives. Bioorg Med Chem
17: 2189–2198.
24. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA (2004) An autocrine
mechanism for constitutive Wnt pathway activation in human cancer cells.
Cancer Cell 6: 497–506.
25. Benhaj K, Akcali KC, Ozturk M (2006) Redundant expression of canonical Wnt
ligands in human breast cancer cell lines. Oncol Rep 15: 701–707.
26. He B, You L, Uematsu K, Xu Z, Lee AY, et al. (2004) A monoclonal antibody
against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6: 7–14.
27. Chen Z, Li J, Li QS, Fan JQ, Dong XM, et al. (2008) Suppression of PPN/
MG61 attenuates Wnt/beta-catenin signaling pathway and induces apoptosis in
human lung cancer. Oncogene 27: 3483–3488.
28. Bartling B, Rehbein G, Simm A, Silber RE, Hofmann HS (2010) Porcupine
expression is associated with the expression of S100P and other cancer-related
molecules in non-small cell lung carcinoma. Int J Oncol 36: 1015–1021.
29. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE (2009) WNT
signaling enhances breast cancer cell motility and blockade of the WNT
Wnt-Independent Effects of PORCN
PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e34532pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer
Res 11: R32.
30. Rajagopalan S, Xu Y, Brenner MB (1994) Retention of unassembled
components of integral membrane proteins by calnexin. Science 263: 387–390.
31. Witheiler J, Wilson DB (1972) The purification and characterization of a novel
peptidase from sheep red cells. J Biol Chem 247: 2217–2221.
32. Huberts DH, van der Klei IJ (2010) Moonlighting proteins: an intriguing mode
of multitasking. Biochim Biophys Acta 1803: 520–525.
33. Jeffery CJ (2009) Moonlighting proteins–an update. Mol Biosyst 5: 345–350.
34. Yang W, Xia Y, Ji H, Zheng Y, Liang J, et al. (2011) Nuclear PKM2 regulates
beta-catenin transactivation upon EGFR activation. Nature.
35. Cox BJ, Vollmer M, Tamplin O, Lu M, Biechele S, et al. (2010) Phenotypic
annotation of the mouse X chromosome. Genome Res 20: 1154–1164.
36. Grzeschik KH, Bornholdt D, Oeffner F, Konig A, del Carmen Boente M, et al.
(2007) Deficiency of PORCN, a regulator of Wnt signaling, is associated with
focal dermal hypoplasia. Nat Genet 39: 833–835.
37. Wang X, Reid Sutton V, Omar Peraza-Llanes J, Yu Z, Rosetta R, et al. (2007)
Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause
focal dermal hypoplasia. Nat Genet 39: 836–838.
38. Froyen G, Govaerts K, Van Esch H, Verbeeck J, Tuomi ML, et al. (2009) Novel
PORCN mutations in focal dermal hypoplasia. Clin Genet 76: 535–543.
Wnt-Independent Effects of PORCN
PLoS ONE | www.plosone.org 11 April 2012 | Volume 7 | Issue 4 | e34532